Join to View Full Profile
5132 Rockville PikeRm 4EBethesda, MD 20892
Phone+1 301-496-5093
Fax+1 301-594-1290
Dr. Dunbar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Boston University Medical CenterResidency, Internal Medicine, 1984 - 1987
Harvard Medical SchoolClass of 1984
Certifications & Licensure
MD State Medical License 1989 - 2026
American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 2003
Clinical Trials
- Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives Start of enrollment: 1996 Mar 18
- Screening for Hematology Branch Protocols Start of enrollment: 1996 Dec 31
- A Pilot Study of the Thrombopoietin-Receptor Agonist Eltrombopag in Refractory Aplastic Anemia Patients Start of enrollment: 2009 May 29
- Join now to see all
Publications & Presentations
PubMed
- Harnessing CD5 to target chimeric antigen receptor-engineered NK cells against invasive fungal infections.Taha Bartu Hayal, Cynthia E Dunbar
Molecular Therapy. 2025-11-14 - 1 citationsClinical and molecular features of immunodeficiency in patients with telomere biology disorders.Luiz Fernando Bazzo Catto, Nidhi Aggarwal, Ruba Shalhoub, Xiaoyang Ma, Ivana Darden
Blood. 2025-09-04 - Kithematopoietic stem cells exhibit distinct lymphoid-primed chromatin landscapes that enhance thymic reconstitution.Harold K Elias, Sneha Mitra, Marina B da Silva, Adhithi Rajagopalan, Brianna Gipson
Nature Communications. 2025-07-04
Abstracts/Posters
- An All Antibody Approach for Conditioning Bone Marrow for Hematopoietic Stem Cell Transplantation with Anti-cKIT and Anti-CD47 in Non-Human PrimatesCynthia E. Dunbar, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Lectures
- Eltrombopag Improves Hematopoiesis in Patients with Low to Intermediate-2 Risk Myelodysplastic Syndrome(MDS)2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Modeling Human Paroxysmal Nocturnal Hemoglobinuria Via CRISPR/Cas9 HSPC Gene Editing in Non-Human Primate2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Press Mentions
With Chemo, Blinatumomab Boosts DFS in Pediatric B-ALLDecember 8th, 2024- Bispecific Combo New Standard for Pediatric Acute Lymphoblastic Leukemia, Experts SayDecember 7th, 2024
- ASH 2024: What Blood Cancer Advances Could Change Practice?December 2nd, 2024
- Join now to see all
Grant Support
- Retroviral Mediated Gene Transfer Into Primate Hematopoietic CellsNational Heart, Lung, And Blood Institute2010–2011
- Gene Transfer And Ex Vivo Manipulation Of Hematopoietic CellsNational Heart, Lung, And Blood Institute1998–2008
- Gene Transfer And Ex Vivo Manipulation Of HematopoieticNational Heart, Lung, And Blood Institute2001–2006
- Gene Transfer To Hematopoietic Progenitor, Stem, And Stromal CellsNational Heart, Lung, And Blood Institute1995–1997
- Gene Transfer To Human Hematopoietic Progenitor, Stem, And Stromal CellsNational Heart, Lung, And Blood Institute1994
- Preclinical And Clinical Gene Transfer To Human Hematopoietic Stem CellsNational Heart, Lung, And Blood Institute1992–1993
- Novel therapies for bone marrow failure and Diamond-Blackfan AnemiaNATIONAL HEART, LUNG, AND BLOOD INSTITUTEPresent
- Macaque models for preclinical development of iPSCsNATIONAL HEART, LUNG, AND BLOOD INSTITUTEPresent
- Clonal and imaging analyses of in vivo hematopoiesis, immune cell ontogeny and adoptive cell therapiesNATIONAL HEART, LUNG, AND BLOOD INSTITUTEPresent
- Optimization of genetic modification of HSCs in the NHP model and creation of relevant preclinical models of human disease and therapiesNATIONAL HEART, LUNG, AND BLOOD INSTITUTEPresent
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
